Completed PHASE2 INTERVENTIONAL 3-arm NCT02601911

Effect of Premedication on Success of Inferior Alveolar Nerve Block Injection

Comparison of Ketorolac and Ketorolac/Acetaminophen on Success of Inferior Alveolar Nerve Block Injection

Sponsor: Azad University of Medical Sciences

Interventions Acetaminophen Ketorolac Tromethamine Placebo

Updated 6 times since 2017 Last updated: Sep 17, 2016 Started: Sep 30, 2015 Primary completion: May 31, 2016 Completion: Jun 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02601911, this PHASE2 trial focuses on Irreversible Pulpitis and remains completed. Sponsored by Azad University of Medical Sciences, it has been updated 6 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Sep 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Azad University of Medical Sciences

Data source: Azad University of Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tehran, Iran